Alex Pellerin

Alex Pellerin has worked in the scientific field since 2007. Alex began their career as a Research Tech at the Immune Disease Institute and then moved on to become an Associate Scientist at Tempero Pharmaceuticals (a GSK company) in 2011. In the same year, they joined Biogen as a Senior Scientist and in 2022 they were appointed as Principal Scientist at Seismic Therapeutic.

Alex Pellerin attended Bowdoin College from 2002 to 2006 and subsequently completed their Doctor of Philosophy - PhD in Molecular Translational Medicine from Boston University in 2021.